Please use this identifier to cite or link to this item:
Title: Informasi Asimetris, Intensitas Riset Dan Pengembangan Dan Terjadinya Underpricing Pada Saat Penawaran Saham Perdana
Authors: Efrata, Tommy C
Keywords: Informasi Asimetris, Underpricing, Intensitas Riset Dan Pengembangan, Farmasi Dan Bioteknologi
Issue Date: 8-Aug-2009
Publisher: Proceeding Konferensi Nasional I – 8 Agustus 2009 – ISBN: 978-602-95291-0-4 – PSEB Fakultas Ekonomi Universitas Kristen Duta Wacana
Citation: Efrata, T. C. (2009). Informasi asimetris, intensitas riset dan pengembangan dan terjadinya underpricing pada saat penawaran saham perdana. In Proceeding Konferensi Nasional I "Dampak Country Risk Terhadap Perusahaan Ditinjau dari Aspek Manajemen & Akuntansi" (pp. 021-037). Retrieved from
Abstract: Asymmetric information between firm's insiders and investors is believed by many financial scholars as the main cause of the underpricing phenomenon during initial public offering (IPO). For the firms within pharmaceutical and biotechnology industries the sources of asymmetric information may come from research and development activities. Using 82 IPO firms in the US, this paper documents a strong association (negative) between IPO initial underpricing and the R&D intensity for the firms in the sectors. The finding of this study suggests that R&D is the main contributor 10 the asymmetric information.
Appears in Collections:Lecture Papers National Published Articles

Files in This Item:
File Description SizeFormat 
345.pdf129.49 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.